Effective patent life of drugs in Sweden - a comparison with international studies

Article Abstract:

The effective patent life (EPL) of new drugs introduced into the Swedish pharmaceutical market was analyzed. Patent protection is important for pharmaceutical research companies because it affords them a chance to receive areturn on their research investments. Data on New Chemical Entities (NCE) registered with the Medical Products Agency from 1965-1988 were investigated. It was discovered that 35.5% of the NCEs did not have patent protection. The average EPL of 12.3 years in 1965 had been shortened to 8.3 years by 1988. It was suggested that patent protection of NCE should be prolonged to maintain theviability of the pharmaceutical industry.

Laws, regulations and rules, Sweden, Intellectual property, Protection and preservation, Patent law, Patents

---

Rx Roulette: combatting counterfeit pharmaceuticals in developing nations

Article Abstract:

Pharmaceutical companies are taking measures to fight drug counterfeiting, particularly in developing countries, such as cooperating with the law enforcement units, monitoring of supply chains, and educating patients and professionals about counterfeit drugs. The strategies employed by pharmaceutical firms were found to have different levels of effectiveness using a theoretical model. The impacts of drug counterfeiting to firm profitability and to public health are examined.

Management dynamics, Developing Countries, Health aspects, Economic aspects, Prevention, Practice, Drug counterfeiting

---

New estimates of pharmaceutical research and development spending by US-based firms from 1984 to 2003

Article Abstract:

Different series for computing reasearch and development spending of pharmaceutical companies for 1984 to 2003 were evaluated. The National Science Foundation Series was found to be a less logical measure, since it reported an 8% growth rate for 1984 to 2002 while PhRMA and Compustat reported it to be 12% and 13%, respectively. Variations in the series are discussed in details.

Product development, Financial management, Science & research, Labor Distribution by Employer, Research, Finance, Measurement, Statistics, Company financing, Costs, Industrial, Industrial costs

Similar abstracts:

• Abstracts: Per capita income convergence and the role of international trade. I just ran two million regressions
• Abstracts: Government relief for risk associated with government action. Second-best insurance contract design in an incomplete market
• Abstracts: Absenteeism: a comparison of incentives in alternative organizations. Decomposing the dividend
• Abstracts: An information based explanation of the domestic bias in international equity investment. Bibliography of Gary Becker's publications, 1952-1992
• Abstracts: An overlapping generations model of climate-economy interactions. Factor taxation, income distribution and capital market integration

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.